Can Hearing Aids Protect Seniors’ Memory? What the Largest Study Ever Found
October 22, 2026 — 65Nation
Hearing loss rarely announces itself. It arrives a little at a time. The television creeps up a notch. Restaurants get harder. You find yourself nodding along in a group conversation and catching up on the details later.
According to the National Institute on Deafness and Other Communication Disorders, about one in three people in the U.S. between 65 and 74 has hearing loss, and nearly half of those older than 75 have difficulty hearing. The institute adds a line worth sitting with: because the loss is gradual, you may not realize you have lost some of your ability to hear.
For years, that was treated as a quality-of-life issue. Then researchers started asking a bigger question. Does untreated hearing loss affect the brain itself?
Why Scientists Started Paying Attention
In 2024, the Lancet Commission on dementia, an international panel of experts, published an updated list of 14 risk factors that could be addressed to prevent or delay dementia. Hearing loss was on it. The commission estimated that about 7 percent of dementia cases worldwide are associated with hearing impairment.
That is a strong association. But an association is a pattern, and a pattern cannot tell you what happens if you act on it. People with hearing loss might develop memory problems for reasons that have nothing to do with their ears. The only way to find out whether treating hearing loss changes anything is to run a proper trial.
So the National Institutes of Health funded one.
The Largest Test of Its Kind
The study is called ACHIEVE, and it was published in The Lancet in July 2023. Researchers at four sites across the United States enrolled 977 adults between 70 and 84 who had untreated hearing loss and no significant memory problems.
Half were randomly assigned to a hearing program: hearing aids for both ears, counseling from an audiologist, and training in how to use them. The other half got a health education program instead, with one-on-one sessions about healthy aging. Everyone was followed for three years with regular memory and thinking tests.
It is the largest randomized trial ever run on this question.
What It Actually Found
Here is the result, stated the way the researchers stated it.
Across the whole group of 977, the hearing program made no measurable difference to the rate of cognitive decline over three years. People who got hearing aids and people who got health classes declined at about the same pace.
That finding deserves to be reported plainly.
But the trial had a second layer, planned before it began. About a quarter of the participants (238 people) came from a long-running heart health study. Compared with the rest, they were older, more likely to have diabetes and high blood pressure, scored lower on memory tests at the start, and were declining about 2.7 times faster.
In that higher-risk group, the hearing program slowed cognitive decline by 48 percent over three years.
The researchers’ interpretation was careful. Hearing intervention may reduce cognitive decline in older adults who are already at higher risk for it. For people who were doing well on their tests and declining slowly, three years was not enough time to see a difference, if one exists. Because the striking result came from a smaller group, the study team is continuing to follow participants to see whether it holds up.
The Benefits Nobody Was Arguing About
Memory was the headline, but it was not the only thing measured.
Participants in the hearing program reported a large improvement in how much their hearing got in the way of daily life. On a standard questionnaire, their average score dropped by half over three years.
A 2025 follow-up analysis published in The Lancet Public Health looked at falls. Over three years, people in the hearing group averaged 1.45 falls compared with 1.98 in the control group, a 27 percent reduction. For people our age, that is no small thing.
What This Means in Practice
Since October 2022, the Food and Drug Administration has allowed hearing aids to be sold over the counter, in stores and online, without an exam or a prescription. They are intended for adults with perceived mild to moderate hearing loss. The FDA says they may not provide enough benefit for more severe loss, and in that case a hearing professional is the right call.
The FDA also lists warning signs that mean you should see a doctor, preferably an ear, nose, and throat specialist, before buying anything: hearing that changed suddenly in the past six months, ringing or buzzing in only one ear, dizziness or a spinning sensation, or ear pain or discharge.
A note on cost. Original Medicare does not cover hearing aids or the exams to fit them. Some Medicare Advantage plans include hearing benefits, so if you have one, it is worth a phone call to ask.
And the NIDCD offers a simple self-check. Its questions are less about volume and more about life: Does a hearing problem make TV or radio difficult? Does it make you feel left out in a group, frustrated talking with family, or inclined to avoid gatherings? Does it cause you to visit friends and relatives less often than you would like? If you answer yes to two or more, the institute suggests having your hearing checked. Your regular doctor, an ENT, or an audiologist can all start that process.
The Bottom Line
The largest trial of its kind did not prove that hearing aids protect everyone’s memory. It found something more specific: for older adults already at higher risk of cognitive decline, treating hearing loss cut that decline nearly in half over three years. It also found fewer falls and easier conversations for everyone who used them.
Hearing loss is common, gradual, and easy to ignore. The research says it may be worth treating for reasons that go well beyond the volume on the television.
